share_log

Ensysce Biosciences | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Matthews Lane Capital Partners LLC(7.9%),Daniel B. Silvers(7.9%), etc.

Ensysce Biosciences | SC 13D/A:超过5%持股股东披露文件(修正)-Matthews Lane Capital Partners LLC(7.9%),Daniel B. Silvers(7.9%)等

2022/07/07 09:08
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息